Robin Farmanfarmaian

Robin Farmanfarmaian is a Silicon Valley based professional speaker and entrepreneur working in cutting edge tech poised to impact 100M people or more. Farmanfarmaian is the CEO and Co-founder of ArO and has been involved with over 20 early-stage biotech and healthcare startups. Her experience spans AI for drug discovery, particularly in small molecules targeting cancer pathways such as p53 and AhR. She has also contributed to medical devices including inhaled insulin and devices for sleep apnea, and co-founded a non-profit that collaborated with DARPA, the DoD, and the White House.

Farmanfarmaian advises companies including Luxsonic Technologies on VR radiology rooms, Alacrity Care on oncology patient monitoring, and ConceptVines, a VC and engineering firm. She has delivered more than 180 speaking engagements across 15 countries, focusing on topics such as the intersection of technology and healthcare, AI, longevity, and shifts in healthcare delivery towards home settings. Farmanfarmaian has authored four books, including "The Patient as CEO: How Technology Empowers the Healthcare Consumer" (2015) and "How AI Can Democratize Healthcare: The Rise in Digital Care" (2022).

Farmanfarmaian is recognized as a professional speaker who delves into healthcare innovation and the role of technology in revolutionizing care delivery. Her talks often explore patient empowerment and how technologies like AI and virtual reality are reshaping the healthcare landscape towards more patient-centered care. Additionally, she highlights the importance of self-care and wellness, framing it around her 4 Pillars of Health: Mindset, Behavioral, Medicine & Diagnostics, and Healthcare Professionals. Her work and message resonate deeply, inspiring audiences to consider how they can be proactive in managing their health through emerging technologies.